Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
Sponsor: Ying Gao
Summary
The primary purpose of this study is to investigate the effectiveness of Ginkgo Diterpene Lactone Meglumine (GDLM) for patients with acute ischemic stroke (AIS) in real-world settings.
Official title: Patients with Acute Ischemic Stroke Receiving Ginkgo Diterpene Lactone Meglumine: a Patient Registry
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
4460
Start Date
2025-03-01
Completion Date
2025-12-31
Last Updated
2025-03-06
Healthy Volunteers
No
Conditions
Interventions
Ginkgo Diterpene Lactone Meglumine
The specific administration protocol (including time of initiation, dosage, and treatment duration) should be strictly adhered to as per the physician's prescription and meticulously documented in the case report forms (CRFs).
Locations (10)
Gansu Provincial People's Hospital
Lanzhou, Gansu, China
Harbin Second Hospital
Harbin, Heilongjiang, China
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Jiangsu Geriatric Hospital
Nanjing, Jiangsu, China
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Nanjing, Jiangsu, China
Xuzhou Hospital of Traditional Chinese Medicine
Xuzhou, Jiangsu, China
The First Hospital of Jilin University
Changchun, Jilin, China
Affiliated Hospital of Jining Medical University
Jining, Shandong, China
Xian Changan District Hospital
Xian, Shanxi, China